X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.20
Delayed Data
As of Apr 24
 -0.0591 / -2.62%
Today’s Change
1.55
Today|||52-Week Range
5.00
+11.16%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.26
Today’s open2.20
Day’s range2.20 - 2.20
Volume250
Average volume (3 months)17,070
Market cap$26.2M
Dividend yield--
Data as of 10:19am ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-83.83%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+153.36%
P/E ratio--
Price/Sales13.65
Price/Book3.98

Competitors

 Today’s
change
Today’s
% change
--Axim Biotechnologies...0.000.00%
TPITianyin Pharmaceutic...-0.01-1.61%
NUINNutrastar Internatio...-0.03-3.93%
EVOKEvoke Pharma Inc+0.05+0.75%
Data as of 3:47pm ET, 04/24/2015

Financials

Last reporting dateSeptember 8, 2008
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$2.4M
Annual profit (last year)-$2.5M
Net profit margin-104.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Herzliya, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers